相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles
Jaime A. Castro-Mondragon et al.
NUCLEIC ACIDS RESEARCH (2022)
Targeted next-generation sequencing of adult gliomas for retrospective prognostic evaluation and up-front diagnostics
J. K. Petersen et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2021)
TERT Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas
Koushik Muralidharan et al.
CLINICAL CANCER RESEARCH (2021)
Molecular Diagnostics of Adult Gliomas in Neuropathological Practice
Sebastian Brandner
Acta medica academica (2021)
Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid
Yutaka Fujioka et al.
JOURNAL OF NEURO-ONCOLOGY (2021)
Prognostic and Predictive Biomarkers in Gliomas
Paulina Sledzinska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Human TERT promoter mutations as a prognostic biomarker in glioma
Branka Powter et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas
Queenie Hoi-Wing Wong et al.
MODERN PATHOLOGY (2021)
TERT Promoter Alterations in Glioblastoma: A Systematic Review
Nathalie Olympios et al.
CANCERS (2021)
Comprehensive Molecular Characterization of Chinese Patients with Glioma by Extensive Next-Generation Sequencing Panel Analysis
Chun Zeng et al.
CANCER MANAGEMENT AND RESEARCH (2021)
Droplet digital PCR assay for detecting TERT promoter mutations in patients with glioma
Jun-Ichi Adachi et al.
BRAIN TUMOR PATHOLOGY (2021)
Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [18F]FET PET radiomics
Zhicong Li et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: clinical implications
Patrick Y. Wen et al.
NEURO-ONCOLOGY (2021)
Establishment and Validation of the Detection of TERT Promoter Mutations by Human Gliomas U251 Cell Lines
Huili Bai et al.
BIOMED RESEARCH INTERNATIONAL (2021)
Advanced Diagnosis of Glioma by Using Emerging Magnetic Resonance Sequences
Ruo-Lun Wei et al.
FRONTIERS IN ONCOLOGY (2021)
Impact of G-Quadruplexes on the Regulation of Genome Integrity, DNA Damage and Repair
Anzhela Pavlova et al.
BIOMOLECULES (2021)
Quantitative MRI-based radiomics for noninvasively predicting molecular subtypes and survival in glioma patients
Jing Yan et al.
NPJ PRECISION ONCOLOGY (2021)
Identification of IDH and TERTp mutation status using 1H-MRS in 112 hemispheric diffuse gliomas
Esin Ozturk-Isik et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2020)
DSC and DCE Histogram Analyses of Glioma Biomarkers, Including IDH, MGMT, and TERT, on Differentiation and Survival
Han-wen Zhang et al.
ACADEMIC RADIOLOGY (2020)
TERT Promoter Mutation Analysis to Distinguish Glioma From Gliosis
Ekkehard Hewer et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2020)
Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study
Md Ismail Hosen et al.
EBIOMEDICINE (2020)
Noninvasive Prediction of TERT Promoter Mutations in High-Grade Glioma by Radiomics Analysis Based on Multiparameter MRI
Hongan Tian et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Characteristics of the isocitrate dehydrogenase gene and telomerase reverse transcriptase promoter mutations in gliomas in Chinese patients
Chong-Xiao Qu et al.
BRAIN AND BEHAVIOR (2020)
Conventional magnetic resonance imaging-based radiomic signature predicts telomerase reverse transcriptase promoter mutation status in grade II and III gliomas
Chendan Jiang et al.
NEURORADIOLOGY (2020)
Highly sensitive detection of TERT promoter mutations in recurrent glioblastomas using digital PCR
Shunichiro Miki et al.
BRAIN TUMOR PATHOLOGY (2020)
A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas
Nayuta Higa et al.
CANCER SCIENCE (2020)
New somatic TERT promoter variants enhance the Telomerase activity in Glioblastoma
Tiziana Pierini et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Current Opinion on Molecular Characterization for GBM Classification in Guiding Clinical Diagnosis, Prognosis, and Therapy
Pei Zhang et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Development of Sensitive Droplet Digital PCR Assays for Detecting Urinary TERT Promoter Mutations as Non-Invasive Biomarkers for Detection of Urothelial Cancer
Ismail Hosen et al.
CANCERS (2020)
Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma
Maxime Fontanilles et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2020)
Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid
Alexandra M. Miller et al.
NATURE (2019)
Urinary TERT promoter mutations as non-invasive biomarkers for the comprehensive detection of urothelial cancer
Patrice Hodonou Avogbe et al.
EBIOMEDICINE (2019)
Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players
Xiaotian Yuan et al.
ONCOGENE (2019)
Clinical Routine TERT Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic Disease
Martin Hysek et al.
CANCERS (2019)
Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation
Cheila Brito et al.
BMC CANCER (2019)
Genomic analysis of primary and recurrent gliomas reveals clinical outcome related molecular features
Longbo Zhang et al.
SCIENTIFIC REPORTS (2019)
MRI Features Associated with TERT Promoter Mutation Status in Glioblastoma
Jana Ivanidze et al.
JOURNAL OF NEUROIMAGING (2019)
Sensitive and rapid detection of TERT promoter and IDH mutations in diffuse gliomas
Bill H. Diplas et al.
NEURO-ONCOLOGY (2019)
Significance of TERT and ATRX mutations in glioma
Jiayu Liu et al.
ONCOLOGY LETTERS (2019)
Prediction of IDH and TERT promoter mutations in low-grade glioma from magnetic resonance images using a convolutional neural network
Ryohei Fukuma et al.
SCIENTIFIC REPORTS (2019)
Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal
Thomas J. Mitchell et al.
CELL (2018)
TERT Promoter Mutation Detection in Cell-Free Tumor-Derived DNA in Patients with IDH Wild-Type Glioblastomas: A Pilot Prospective Study
Tareq A. Juratli et al.
CLINICAL CANCER RESEARCH (2018)
Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas
Cemaliye B. Akyerli et al.
JOURNAL OF NEUROSURGERY (2018)
Clinical implications of TERT promoter mutation on IDH mutation and MGMT promoter methylation in diffuse gliomas
Hyun Sik Kim et al.
PATHOLOGY RESEARCH AND PRACTICE (2018)
Elevated TERT Expression in TERT-Wildtype Adult Diffuse Gliomas: Histological Evaluation with a Novel TERT-Specific Antibody
Kenta Masui et al.
BIOMED RESEARCH INTERNATIONAL (2018)
The TERT promoter mutation status and MGMT promoter methylation status, combined with dichotomized MRI-derived and clinical features, predict adult primary glioblastoma survival
Chang Shu et al.
CANCER MEDICINE (2018)
Pathological prognostic markers in central nervous system solitary fibrous tumour/hemangiopericytoma: Evidence from a small series
Luca Bertero et al.
PLOS ONE (2018)
Structural basis for reactivating the mutant TERT promoter by cooperative binding of p52 and ETS1
Xueyong Xu et al.
NATURE COMMUNICATIONS (2018)
Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics
Nathalie E. Synhaeve et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Molecular Diagnostics of Gliomas Using Next Generation Sequencing of a Glioma-Tailored Gene Panel
Angela Zacher et al.
BRAIN PATHOLOGY (2017)
TERT Promoter Mutations Occur Frequently in Urothelial Papilloma and Papillary Urothelial Neoplasm of Low Malignant Potential
Liang Cheng et al.
EUROPEAN UROLOGY (2017)
Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas
Khalil Abou-El-Ardat et al.
NEURO-ONCOLOGY (2017)
Glioma Subclassifications and Their Clinical Significance
Ricky Chen et al.
NEUROTHERAPEUTICS (2017)
Mass spectrometry-based assay for the molecular diagnosis of glioma: concomitant detection of chromosome 1p/19q codeletion, and IDH1, IDH2, and TERT mutation status
Chiara Pesenti et al.
ONCOTARGET (2017)
The frequency and prognostic effect of TERT promoter mutation in diffuse gliomas
Yujin Lee et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Same-day genomic and epigenomic diagnosis of brain tumors using real-time nanopore sequencing
Philipp Euskirchen et al.
ACTA NEUROPATHOLOGICA (2017)
Paradoxical prognostic impact of TERT promoter mutations in gliomas depends on different histological and genetic backgrounds
Hao You et al.
CNS NEUROSCIENCE & THERAPEUTICS (2017)
Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT
Melike Pekmezci et al.
ACTA NEUROPATHOLOGICA (2017)
Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets
Felix Sahm et al.
ACTA NEUROPATHOLOGICA (2016)
Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial
Hendrikus J. Dubbink et al.
NEURO-ONCOLOGY (2016)
Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors
Marina N. Nikiforova et al.
NEURO-ONCOLOGY (2016)
TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas
Ke Gao et al.
ONCOTARGET (2016)
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
Michele Ceccarelli et al.
CELL (2016)
The Sensitive Detection of Telomerase Reverse Transcriptase Promoter Mutation by Amplification Refractory Mutation System-PCR
Jinbo Liu et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2016)
TERT mutation in glioma: Frequency, prognosis and risk
Yang Yuan et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2016)
Classification based on mutations of TERT promoter and IDH characterizes subtypes in grade II/III gliomas
Pei Yang et al.
NEURO-ONCOLOGY (2016)
Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies
Mohammad A. Jafri et al.
GENOME MEDICINE (2016)
A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas
Hideyuki Arita et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation
Dong-Sheng Huang et al.
EUROPEAN JOURNAL OF CANCER (2015)
Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation
Yinghui Li et al.
NATURE CELL BIOLOGY (2015)
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
Jeanette E. Eckel-Passow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The Genetic Evolution of Melanoma from Precursor Lesions
A. Hunter Shain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
Robert J. A. Bell et al.
SCIENCE (2015)
TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma
Mohamed Ali Mosrati et al.
ONCOTARGET (2015)
TERT promoter mutations contribute to IDH mutations in predicting differential responses to adjuvant therapies in WHO grade II and III diffuse gliomas
Zhen-Yu Zhang et al.
ONCOTARGET (2015)
TERT promoter mutations and telomere length in adult malignant gliomas and recurrences
Barbara Heidenreich et al.
ONCOTARGET (2015)
TERT promoter mutations contribute to subset prognostication of lower-grade gliomas
Aden Ka-Yin Chan et al.
MODERN PATHOLOGY (2015)
TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations
M. Labussiere et al.
BRITISH JOURNAL OF CANCER (2014)
TERT Promoter Mutation as an Early Genetic Event Activating Telomerase in Follicular Thyroid Adenoma (FTA) and Atypical FTA
Na Wang et al.
CANCER (2014)
Telomerase Reverse Transcriptase Promoter Mutation Is an Early Somatic Genetic Alteration in the Transformation of Premalignant Nodules in Hepatocellular Carcinoma on Cirrhosis
Jean Charles Nault et al.
HEPATOLOGY (2014)
TERT promoter mutations in primary and secondary glioblastomas
Naosuke Nonoguchi et al.
ACTA NEUROPATHOLOGICA (2013)
Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss
Hideyuki Arita et al.
ACTA NEUROPATHOLOGICA (2013)
Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system
Christian Koelsche et al.
ACTA NEUROPATHOLOGICA (2013)
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
Patrick J. Killela et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Highly Recurrent TERT Promoter Mutations in Human Melanoma
Franklin W. Huang et al.
SCIENCE (2013)
Molecular Neuropathology of Gliomas
Markus J. Riemenschneider et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2009)
分享论文
